Prospect News: News for Hemagen Diagnostics Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with H > Issuers starting with H, PP only > All stories on Hemagen Diagnostics Inc. > Stories on Hemagen Diagnostics Inc., PP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Hemagen Diagnostics Inc.

7/6/2012	PP	Hemagen asks holders to forgo coupon payments for 8% convertibles
10/1/2009	PP	Hemagen completes exchange offer for $4.05 million in 8% convertibles
9/1/2009	PP	Hemagen offers to exchange all 8% convertibles due 2009 for new notes
12/22/2004	PP	New Issue: Hemagen closes exchange offer on $6.09 million in notes
12/17/2004	PP	Hemagen again extends exchange offer on $6.09 million convertible notes
12/3/2004	PP	Hemagen extends exchange offer on $6.09 million convertible notes
11/30/2004	PP	Hemagen Diagnostics again extends exchange offer on 8% convertible notes
11/22/2004	PP	Hemagen extends exchange offer on 8% senior secured convertibles yet again
11/15/2004	PP	Hemagen extends exchange offer on $6.09 million in convertible notes
11/1/2004	PP	Hemagen extends exchange offer for $6.09 million 8% convertible notes
10/18/2004	PP	Hemagen extends exchange offer on $6.09 million in 8% convertible notes

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.